These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 36077559)
1. TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway. Gu H; Zhu S; Peng C; Wei Z; Shen Y; Yuan C; Yang H; Cui H; Yang L Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077559 [TBL] [Abstract][Full Text] [Related]
2. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance. Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752 [TBL] [Abstract][Full Text] [Related]
3. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway. Han S; Zhen W; Guo T; Zou J; Li F J Exp Clin Cancer Res; 2020 Oct; 39(1):218. PubMed ID: 33059737 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926 [TBL] [Abstract][Full Text] [Related]
5. USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis. Wang Y; Luo X; Wu N; Liao Q; Wang J J Cancer Res Ther; 2023 Feb; 19(1):97-107. PubMed ID: 37006049 [TBL] [Abstract][Full Text] [Related]
6. SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway. Wang Y; Luo X; Wu N; Liao Q; Wang J Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts. Zhu L; Zhang S; Huan X; Mei Y; Yang H Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350 [TBL] [Abstract][Full Text] [Related]
8. TRAF4 promotes tumorigenesis of breast cancer through activation of Akt. Zhang J; Li X; Yang W; Jiang X; Li N Oncol Rep; 2014 Sep; 32(3):1312-8. PubMed ID: 24993240 [TBL] [Abstract][Full Text] [Related]
9. The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1. Yu W; Singh R; Wang Z; O'Malley BW; Yi P J Biol Chem; 2021; 296():100739. PubMed ID: 33991522 [TBL] [Abstract][Full Text] [Related]
10. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway. Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. Wang X; Jin C; Tang Y; Tang LY; Zhang YE J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265 [TBL] [Abstract][Full Text] [Related]
12. miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis. Shi C; Rao C; Sun C; Yu L; Zhou X; Hua D; Wang R; Luo W; Jiang Z; Zhou J; Wang Q; Yu S Cell Death Dis; 2018 Oct; 9(11):1078. PubMed ID: 30348972 [TBL] [Abstract][Full Text] [Related]
14. MiR-29a Inhibits Glioma Tumorigenesis through a Negative Feedback Loop of TRAF4/Akt Signaling. Liu Y; Duan N; Duan S Biomed Res Int; 2018; 2018():2461363. PubMed ID: 30186853 [TBL] [Abstract][Full Text] [Related]
15. TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance. Liao J; Qing X; Li X; Gan Y; Wang R; Han S; Li W; Song W Int J Biol Sci; 2024; 20(1):182-199. PubMed ID: 38164179 [TBL] [Abstract][Full Text] [Related]
16. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway. Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938 [TBL] [Abstract][Full Text] [Related]
17. TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2. Li J; Wang P; Xie Z; Wang S; Cen S; Li M; Liu W; Tang S; Ye G; Zheng G; Su H; Ma M; Wu X; Wu Y; Shen H Cell Death Differ; 2019 Dec; 26(12):2652-2666. PubMed ID: 31076633 [TBL] [Abstract][Full Text] [Related]
18. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1. Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652 [TBL] [Abstract][Full Text] [Related]
19. TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling. Iyengar PV; Marvin DL; Lama D; Tan TZ; Suriyamurthy S; Xie F; van Dinther M; Mei H; Verma CS; Zhang L; Ritsma L; Ten Dijke P Mol Cancer Res; 2022 Oct; 20(10):1516-1531. PubMed ID: 35731212 [TBL] [Abstract][Full Text] [Related]
20. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]